A meta-analysis of the effect of combinations of immune modulating nutrients on outcome in patients undergoing major open Gastrointestinal Surgery

Annals of Surgery

Volumn 255, Issue 6, 2012, Pages 1060-1068

  Marimuthu, Kanagaraj ^a   Varadhan, Krishna K ^a   Ljungqvist, Olle ^b   Lobo, Dileep N ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; IMMUNOMODULATING AGENT; NUCLEOTIDE; OMEGA 3 FATTY ACID;

ARTICLE; CONFIDENCE INTERVAL; GASTROINTESTINAL SURGERY; HUMAN; IMMUNOMODULATION; INCIDENCE; LENGTH OF STAY; META ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGICAL MORTALITY;

DIGESTIVE SYSTEM DISEASES; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENTERAL NUTRITION; FOOD; FOOD, FORMULATED; HUMANS; IMMUNOLOGIC FACTORS; LENGTH OF STAY; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84861344076     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318252edf8     Document Type: Article

References (64)

1. Bisgaard T, Kehlet H. Early oral feeding after elective abdominal surgery-what are the issues? Nutrition. 2002;18:944-948. (Pubitemid 35304804)
2. Heys SD, Walker LG, Smith I, et al. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg. 1999;229:467-477. (Pubitemid 30191743)
3. Heyland DK, Novak F, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA. 2001;286:944-953. (Pubitemid 33010341)
4. Kirk HJ, Heys SD. Immunonutrition. Br J Surg. 2003;90:1459-1460. (Pubitemid 37533160)
5. Akbarshahi H, Andersson B,NordenM, et al. Perioperative nutrition in elective gastrointestinal surgery-potential for improvement? Dig Surg. 2008;25:165-174.
6. Marik PE, Zaloga GP. Immunonutrition in high-risk surgical patients: a systematic review and analysis of the literature. JPEN J Parenter Enteral Nutr. 2010;34:378-386.
7. Cerantola Y, Hubner M, Grass F, et al. Immunonutrition in gastrointestinal surgery. Br J Surg. 2011;98:37-48.
8. Bertolini G, Iapichino G, Radrizzani D, et al. Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med. 2003;29:834-840. (Pubitemid 36609578)
9. Sacks GS, Genton L, Kudsk KA. Controversy of immunonutrition for surgical critical-illness patients. Curr Opin Crit Care. 2003;9:300-305. (Pubitemid 36930374)
10. Helminen H, Raitanen M, Kellosalo J. Immunonutrition in elective gastrointestinal surgery patients. Scand J Surg. 2007;96:46-50. (Pubitemid 46493764)
11. Mudge L, Isenring E, Jamieson GG. Immunonutrition in patients undergoing esophageal cancer resection. Dis Esophagus. 2011;24:160-165.
12. Bower RH, Cerra FB, Bershadsky B, et al. Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med. 1995;23:436-449.
13. Atkinson S, Sieffert E, Bihari D. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Guy's Hospital Intensive Care Group. Crit Care Med. 1998;26:1164-1172. (Pubitemid 28334968)
14. Kieft H, Roos AN, van Drunen JD, et al. Clinical outcome of immunonutrition in a heterogeneous intensive care population. Intensive Care Med. 2005;31:524-532. (Pubitemid 40543883)
15. Montejo JC, Zarazaga A, Lopez-Martinez J, et al. Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr. 2003;22:221-233. (Pubitemid 36701636)
16. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med. 2008;34:1980-1990.
17. Lecleire S, Hassan A,Marion-Letellier R, et al. Combined glutamine and arginine decrease proinflammatory cytokine production by biopsies from Crohn's patients in associationwith changes in nuclear factor-kappaB and p38 mitogenactivated protein kinase pathways. J Nutr. 2008;138:2481-2486.
18. Kul M, Vurucu S, Demirkaya E, et al. Enteral glutamine and/or arginine supplementation have favorable effects on oxidative stress parameters in neonatal rat intestine. J Pediatr Gastroenterol Nutr. 2009;49:85-89.
19. Gennari R, Alexander JW, Eaves-Pyles T. Effect of different combinations of dietary additives on bacterial translocation and survival in gut-derived sepsis. JPEN J Parenter Enteral Nutr. 1995;19:319-325.
20. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401-406.
21. Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence-study limitations (risk of bias). J Clin Epidemiol. 2011;64:407-415.
22. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17: 1-12. (Pubitemid 26120810)
23. Higgins JPT, Green S, ed. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2009. Available at: http://www.cochrane-handbook.org/. Accessed January 2, 2011.
24. GRADEpro [Computer program]. Version 3.2 for Windows. 2008. Available at: http://ims.cochrane.org/revman/other-resources/gradepro/download. Accessed April 24, 2011.
25. Daly JM, Lieberman MD, Goldfine J, et al. Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery. 1992;112:56-67.
26. Daly JM, Weintraub FN, Shou J, et al. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995;221:327-338.
27. Schilling J, Vranjes N, Fierz W, et al. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide-enriched enteral feeding: a randomized prospective comparison with standard enteral and low calorie/low fat i.v. solutions. Nutrition. 1996;12:423-429.
28. Wachtler P, Axel Hilger R, KonigW, et al. Influence of a pre-operative enteral supplement on functional activities of peripheral leukocytes from patients with major surgery. Clin Nutr. 1995;14:275-282.
29. Gianotti L, BragaM,Vignali A, et al. Effect of route of delivery and formulation of postoperative nutritional support in patients undergoing major operations for malignant neoplasms. Arch Surg. 1997;132:1222-1229; discussion 1229-1230.
30. SenkalM,Mumme A, EickhoffU, et al. Early postoperative enteral immunonutrition: clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med. 1997;25:1489-1496. (Pubitemid 27391477)
31. BragaM, Gianotti L, Vignali A, et al. Artificial nutrition after major abdominal surgery: impact of route of administration and composition of the diet. Crit Care Med. 1998;26:24-30. (Pubitemid 28028436)
32. McCarter MD, Gentilini OD, Gomez ME, et al. Preoperative oral supplement with immunonutrients in cancer patients. JPEN J Parenter Enteral Nutr. 1998;22:206-211. (Pubitemid 28307582)
33. Braga M, Gianotti L, Radaelli G, et al. Perioperative immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind phase 3 trial. Arch Surg. 1999;134:428-433. (Pubitemid 29282087)
34. Senkal M, Zumtobel V, Bauer KH, et al. Outcome and cost-effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: a prospective randomized study. Arch Surg. 1999;134:1309-1316.
35. Jiang ZM, Gu ZY, Chen FL, et al. The role of immune enhanced enteral nutrition on plasma amino acid, gut permeability and clinical outcome (a randomized, double blind, controlled, multi-center clinical trailwith 120 cases). Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001;23:515-518.
36. Braga M, Gianotti L, Vignali A, et al. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery. 2002;132:805-814. (Pubitemid 36307818)
37. Jiang XH, Li N, Zhu WM, et al. Effects of postoperative immune-enhancing enteral nutrition on the immune system, inflammatory responses, and clinical outcome. Chin Med J (Engl). 2004;117:835-839. (Pubitemid 38961674)
38. Farreras N, Artigas V, Cardona D, et al. Effect of early postoperative enteral immunonutrition on wound healing in patients undergoing surgery for gastric cancer. Clin Nutr. 2005;24:55-65.
39. Yao G, Xue X, Liu X, et al. Effects of postoperative enteral immune-enhancing diet on plasma endotoxin level, plasma endotoxin inactivation capacity and clinical outcome. J Huazhong Univ Sci Technolog Med Sci. 2005;25:431-434.
40. Satinsky I, Mittak M, Foltys A, et al. Comparison various types of artificial nutrition on postoperative complications after major surgery. Rozhl Chir. 2005;84:134-141.
41. Lobo DN, Williams RN, Welch NT, et al. Early postoperative jejunostomy feeding with an immune modulating diet in patients undergoing resectional surgery for upper gastrointestinal cancer: a prospective, randomized, controlled, double-blind study. Clin Nutr. 2006;25:716-726. (Pubitemid 44426436)
42. Xu J, Zhong Y, Jing D, et al. Preoperative enteral immunonutrition improves postoperative outcome in patients with gastrointestinal cancer. World J Surg. 2006;30:1284-1289. (Pubitemid 44078418)
43. Klek S, Kulig J, Sierzega M, et al. The impact of immunostimulating nutrition on infectious complications after upper gastrointestinal surgery: a prospective, randomized, clinical trial. Ann Surg. 2008;248:212-220.
44. Klek S, Kulig J, Sierzega M, et al. Standard and immunomodulating enteral nutrition in patients after extended gastrointestinal surgery-a prospective, randomized, controlled clinical trial. Clin Nutr. 2008;27:504-512.
45. Gunerhan Y, Koksal N, Sahin UY, et al. Effect of preoperative immunonutrition and other nutrition models on cellular immune parameters. World J Gastroenterol. 2009;15:467-472.
46. Okamoto Y, Okano K, Izuishi K, et al. Attenuation of the systemic inflammatory response and infectious complications after gastrectomy with preoperative oral arginine and omega-3 fatty acids supplemented immunonutrition. World J Surg. 2009;33:1815-1821.
47. Sodergren MH, Jethwa P, Kumar S, et al. Immunonutrition in patients undergoing major upper gastrointestinal surgery: a prospective double-blind randomised controlled study. Scand J Surg. 2011;99:153-161.
48. Klek S, Sierzega M, Szybinski P, et al. The immunomodulating enteral nutrition in malnourished surgical patients-a prospective, randomized, double-blind clinical trial. Clin Nutr. 2011;30:282-288.
49. Di Carlo V, Gianotti L, Balzano G, et al. Complications of pancreatic surgery and the role of perioperative nutrition. Dig Surg. 1999;16:320-326. (Pubitemid 29376334)
50. Erdem NZ, Kulacoglu IH, Temel MA, et al. Perioperative oral supplement with immunonutrients in gastrointestinal cancer patients. Turk J Med Sci. 2001;31:79-86.
51. Braga M, Gianotti L, Nespoli L, et al. Nutritional approach in malnourished surgical patients: a prospective randomized study. Arch Surg. 2002;137:174-180. (Pubitemid 34142134)
52. Gianotti L, Braga M, Nespoli L, et al. A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology. 2002;122:1763-1770. (Pubitemid 34651419)
53. Finco C, Magnanini P, Sarzo G, et al. Prospective randomized study on perioperative enteral immunonutrition in laparoscopic colorectal surgery. Surg Endosc. 2007;21:1175-1179. (Pubitemid 47024759)
54. Heslin MJ, Latkany L, Leung D, et al. A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg. 1997;226:567-577; discussion 577-580.
55. Pronio A, Di Filippo A, Aguzzi D, et al. Treatment of mild malnutrition and reduction of morbidity in major abdominal surgery: randomized trial on 153 patients. Clin Ter. 2008;159:13-18. (Pubitemid 351363577)
56. Suzuki D, Furukawa K, Kimura F, et al. Effects of perioperative immunonutrition on cell-mediated immunity, T helper type 1 (Th1)/Th2 differentiation, and Th17 response after pancreaticoduodenectomy. Surgery. 2010;148:573-581.
57. Beale RJ, Bryg DJ, BihariDJ. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med. 1999;27:2799-2805. (Pubitemid 30027200)
58. Braga M, Gianotti L. Preoperative immunonutrition: cost-benefit analysis. JPEN J Parenter Enteral Nutr. 2005;29 (1 Suppl):S57-S61.
59. Braga M, Gianotti L, Vignali A, et al. Immunonutrition in gastric cancer surgical patients. Nutrition. 1998;14:831-835. (Pubitemid 28547522)
60. Gianotti L, Braga M, Gentilini O, et al. Artificial nutrition after pancreaticoduodenectomy. Pancreas. 2000;21:344-351.
61. Huhmann MB, August DA. Nutrition support in surgical oncology. Nutr Clin Pract. 2009;24:520-526.
62. WeimannA, Braga M, Harsanyi L, et al. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr. 2006;25:224-244. (Pubitemid 43832525)
63. Mendez C, Jurkovich GJ, Garcia I, et al. Effects of an immune-enhancing diet in critically injured patients. J Trauma. 1997;42:933-940; discussion 940-941.
64. Kudsk KA, Minard G, Croce MA, et al. A randomized trial of isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic complications. Ann Surg. 1996;224:531-540; discussion 540-543.